由Elexacaftor/Tezacaftor/Ivacaftor诱导的延迟状药物喷发
Tatiana Ninkov1, Megan Yap2, Nima Mesbah Ardakani3,4
1Sir Charles Gairdner Hospital, Nedlands, Australia.
Pediatric dermatology
|December 29, 2025
概括
治疗囊性纤维化症的三重疗法elexacaftor/tezacaftor/ivacaftor可能会导致皮肤反应延迟. 这份病例报告详细介绍了一种罕见的延迟状药物喷发和药物的成功重新引入.
科学领域:
- 药理学 药理学是指药理学的学科.
- 皮肤病学 皮肤病学
- 肺部病理学 肺部病理学
背景情况:
- 埃莱克萨卡夫托/特萨卡夫托/伊瓦卡夫托是治疗囊性纤维化症的三重治疗药物.
- 严重的皮肤不良反应 (SCAR) 是罕见的,通常在治疗开始后一个月内发生.
研究的目的:
- 报告一个独特的延迟球状药物喷发病例,归因于elexacaftor/tezacaftor/ivacaftor.
- 为了探索延迟SCAR后药物重新挑战的潜力.
主要方法:
- 一个囊性纤维化患者的病例报告经历了延迟的状药物喷发.
- 对不良事件和随后的药物重新引入的文件.
主要成果:
- 一位患者在开始使用elexacaftor/tezacaftor/ivacaftor两年后出现了巨型药物喷发.
- 患者在喷发消失后成功地忍受了三重治疗的重新引入.
结论:
- 从elexacaftor/tezacaftor/ivacaftor延迟的SCAR是可能的,比以前报告的时间晚得多.
- 在某些延迟不良反应的特定情况下,成功的药物重新挑战可能是可行的.
相关概念视频
Allergic Drug Reactions
1.3K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.3K
Drugs for Treatment of Diarrhea-Predominant IBS
593
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
593
Drugs for Treatment of Ulcerative Colitis in IBD
416
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
416
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
1.3K
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
1.3K
Pulmonary Tuberculosis IV
467
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
467
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
212
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
212


